VCM
PTLA

Vivaldi Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Vivaldi Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,237
Closed -$202K – 320
2020
Q2 		$202K Buy
+11,237
New +$156K 0.04% 245

Vivaldi Capital Management's PTLA Position: Q3 2020 in Review

Vivaldi Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 11,237 shares — an estimated $202K sold.

Vivaldi Capital Management first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $202K in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Vivaldi Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Vivaldi Capital Management sold 11,237 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $202K.
  • Vivaldi Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Vivaldi Capital Management's Portola Pharmaceuticals, Inc. position peaked at $202K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Vivaldi Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.